Evaluation of18F-FDG uptake and arterial wall calcifications using18F-FDG PET/CT

Journal of Nuclear Medicine

Volumn 45, Issue 11, 2004, Pages 1816-1821

  Ben Haim, Simona ^a,b   Kupzov, Ela ^c   Tamir, Ada ^a,b   Israel, Ora ^b,c  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Arterial calcifications; Atherosclerosis; Hybrid imaging; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VASCULAR LESION; ANGIOGRAPHY; ARTERIOSCLEROSIS; ARTERY; CALCINOSIS; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ARTERIES; ARTERIOSCLEROSIS; CALCINOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 16244393899     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pasterkamp G, Falk E, Woutman H, Borst C. Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making? J Am Coll Cardiol. 2000;36:13-21.
2. Gussenhoven EJ, Essed CE, Lancee CT, et al. Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study. J Am Coll Cardiol. 1989;14:947-952.
3. Peters RJG, Kok WEM, Havenith MG, Rijsterborgh H, van der Wal AC, Visser CA. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiography. 1994;7:230-241.
4. Siegel RJ, Ariani M, Fishbein MC, et al. Histopathologic validation of angioscopy and intravascular ultrasound. Circulation. 1991;84:109 -117.
5. Stefanadis C, Diamantopoulos L, Vlachopolos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo. Circulation. 1999;99:1965-1971.
6. Galbraith J, Murphy M, de Soyza N. Coronary angiogram interpretation: interobserver variability. JAMA. 1978;240:2053-2056.
7. Raggi P. Coronary calcium on electron beam tomography imaging as a surrogate marker of coronary artery disease. Am J Cardiol. 2001;87:27A-34A.
8. Toussaint J, LaMuraglia G, Southern J, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932-938.
9. Helft G, Worthley S, Fuster V, et al. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. J Am Coll Cardiol. 2001;37:1149-1154.
10. Moser KW, O'Keefe JH, Bateman TM, McGhie IA. Coronary calcium screening in asymptomatic patients as a guide to risk factor modification and stress myocardial perfusion imaging. J Nucl Cardiol. 2003;10:590 -598.
11. Vallabhajosula S, Paidi M, Badimon JJ, et al. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m preparations. J Nucl Med. 1988;29:1237-1245.
12. Fishman AJ, Rubin RH, Khaw BA, et al. Radionuclide imaging of experimental atherosclerosis with non-specific polyclonal immunoglobulin G. J Nucl Med. 1989;30:1095-1100.
13. Demacker PNM, Dormans TPJ, Koenders EB, Corstens FHM. Evaluation of Indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol. J Nucl Med. 1993;34:1316-1321.
14. Yun M, Yeh D, Araucho LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries. a new observation. Clin Nucl Med. 2001;26:314-319.
15. Lederman RJ, Raylman RR, Fisher SJ, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun. 2001;22:747-753.
16. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
17. 18FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med. 2002;37:70-76.
18. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200-1209.
19. Turlakow A, Yeung HW, Pui J, et al. Fluorodeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med. 2001;161:1003-1007.
20. 18FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging. 2003;30:1305-1313.
21. Vallabhajosula S, Machac J, Knesaurek K, et al. Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose (FDG) [abstract]. J Nucl Med. 1996;37(suppl):38P.
22. Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med. 1997;38:1788-1796.
23. Leeuw de K, Bijl M, Jager PL. Value of FDG PET in diagnosis and follow-up of patients with Takayasu arteritis [abstract]. J Nucl Med. 2003;44(suppl):46P.
24. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229:831-837.
25. Hanif MZ, Ghesani M, Shah AA, Kasai T. F-18 Fluorodeoxyglucose uptake in atherosclerotic plaque in the mediastinum mimicking malignancy: another potential for error. Clin Nucl Med. 2004;29:93-95.